Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ACTRN12626001100381) titled 'Psilocybin-assisted treatment for methamphetamine use disorder: A multi-site randomised controlled trial (PsiMA RCT)' on Sept. 4.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Efficacy
Primary Sponsor: University of New South Wales
Condition:
Methamphetamine Use Disorder
Methamphetamine Use Disorder
Mental Health - Addiction
Intervention:
Intervention: Psilocybin-assisted psychotherapy (PAT-25)
International Non-proprietary Name (INN): Psilocybin
Dose: Single 25 mg oral dose of...